Unassociated Document
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM 8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of
report (Date of earliest event reported): December 31, 2009
PATIENT
SAFETY TECHNOLOGIES, INC.
(Exact
Name of Registrant as Specified in Charter)
DELAWARE
|
|
001-09727
|
|
13-3419202
|
(State
or Other Jurisdiction
of
Incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer
Identification
No.)
|
|
|
|
|
|
43460
Ridge Park Drive, Suite 140
Temecula,
California
|
|
92590
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
(951)
587-6201
(Registrant’s
telephone number, including area code)
N/A
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the Registrant under any of the following
provisions:
o
|
Written
communications pursuant to Rule 425 under the Securities Act of 1933,
as amended (17 CFR 230.425)
|
|
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Securities Exchange Act of
1934, as amended (17 CFR 240.14a-12)
|
|
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Securities
Exchange Act of 1934, as amended (17 CFR 240.14d-2(b))
|
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Securities
Exchange Act of 1934, as amended (17 CFR
240.13e-4(c))
|
|
Entry
into a Material Definitive
Agreement
|
On December 31, 2009, we entered into a
sublease (the “Sublease”) with
Reliance Life Sciences, Inc. for approximately 5,670 square feet of office space
located at 5 Caufield Place, Newtown, Pennsylvania to serve as our principal
administrative headquarters. We intend to continue to maintain our
premises in Temecula, California and will gradually transition operations to our
new administrative headquarters in Pennsylvania upon effectiveness of the
Sublease.
The term of the Sublease will begin on
the later of (i) January 1, 2010 or (ii) the date written consent of the
landlord to the Sublease is obtained. The Sublease term will expire
April 30, 2013, unless earlier terminated in accordance with the
Sublease. In addition to base rent ($11,576.25 per month), we will be
responsible for certain costs and charges specified in the Sublease, including
taxes, utilities, insurance and maintenance costs.
The foregoing summary of the terms of
the Sublease does not purport to be complete and is qualified in its entirety by
reference to the Sublease, a copy of which is filed as Exhibit 10.1 to this Form
8-K and is incorporated herein by this reference.
|
Financial
Statements and Exhibits
|
(c)
Exhibits.
Exhibit
Number
|
|
Description
of Exhibits
|
10.1
|
|
Sublease
Agreement by and between the registrant and Reliance Life Sciences, Inc.
for premises at 5 Caufield Place, Suite 102, Newton, PA 18940 dated
December 31, 2009
|
|
|
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
PATIENT
SAFETY TECHNOLOGIES, INC.
|
|
|
|
|
|
January
7, 2010
|
By:
|
/s/ Marc
L. Rose
|
|
|
|
Name: Marc
L. Rose
|
|
|
|
Title:
Chief Financial Officer
|
|
|
|
|
|